The term "PMEI28 Antibody" does not appear in any of the provided sources ( ) or in standard antibody databases such as The Antibody Society’s therapeutic product list or the Histone Antibody Specificity Database .
Nomenclature Discrepancy: The name may involve typographical errors, non-standard formatting (e.g., "PMEI-28"), or alternative identifiers (e.g., catalog numbers, gene targets).
Research Stage: The antibody might be in early preclinical development without published data.
Proprietary Status: It could be a proprietary compound under confidential development by a pharmaceutical or biotech company.
To resolve this ambiguity, consider the following steps:
While PMEI28 remains uncharacterized, below is a comparative overview of well-studied antibody types for reference:
If PMEI28 is a novel antibody, adhere to best practices for validation :
KEGG: osa:4344463
UniGene: Os.5834
PMEI28 is a pectin methylesterase inhibitor protein found in Oryza sativa (rice). Like other PMEIs, it functions by regulating the activity of pectin methylesterases (PMEs), which are enzymes that catalyze the demethylesterification of homogalacturonan domains of pectin in the plant cell wall . This regulation is crucial for:
Maintaining cell wall integrity during pathogen attacks
Controlling pectin degradation as part of the plant immune response
Influencing the methylesterification status of pectin, which can affect plant resistance to diseases
PMEIs like PMEI28 form specific and stable complexes with PMEs in a 1:1 stoichiometry, effectively covering the pectin-binding cleft of PME and concealing the putative catalytic sites, thereby preventing substrate approach .
The PMEI28 antibody is produced through standard immunization protocols using either purified PMEI28 protein or synthetic peptides corresponding to specific regions of the PMEI28 sequence. Based on general antibody production methodologies and available information on similar antibodies :
Production Process:
Synthesis of immunogens (full protein or peptide fragments)
Immunization of host animals (typically rabbits for polyclonal antibodies)
Collection and purification of antibodies
Validation through specificity testing
Validation Methods:
Western blotting against purified PMEI28 and plant tissue extracts
Immunohistochemistry on plant tissues
ELISA to determine binding affinity and specificity
Cross-reactivity testing against related PMEIs
Researchers should verify the antibody's specificity through appropriate controls, including pre-immune serum and testing in PMEI28 knockout plant tissues .
Based on the applications of similar PMEI antibodies, the PMEI28 antibody can be used for :
Western blotting: To detect and quantify PMEI28 expression in different plant tissues, developmental stages, or in response to stress conditions.
Immunohistochemistry/Immunofluorescence: To localize PMEI28 protein in plant tissues and cells, providing insights into its spatial distribution.
ELISA: For quantitative detection of PMEI28 in plant extracts.
Tissue printing: To detect and localize PMEI28 in fresh plant tissue sections.
Immunoprecipitation: To isolate PMEI28 and its interacting partners from plant extracts.
| Application | Recommended Dilution | Sample Preparation | Detection Method |
|---|---|---|---|
| Western Blot | 1:500-1:3000 | Total protein extraction with buffer containing protease inhibitors | HRP-conjugated secondary antibody |
| Immunohistochemistry | 1:20-1:200 | Fixation with 4% paraformaldehyde, paraffin embedding | DAB or fluorescent detection |
| ELISA | 1:1000-1:5000 | Protein extraction in carbonatebuffer (pH 9.6) | TMB substrate |
| Immunoprecipitation | 5 μg antibody per 1 mg total protein | Extraction in non-denaturing conditions | Protein A/G beads |
Optimizing antibody titration for PMEI28 detection requires systematic testing of different concentrations, as antibody performance can vary across tissue types and experimental conditions. Based on studies with similar antibodies :
Recommended Titration Approach:
Start with a fourfold dilution series (e.g., 1:500, 1:2000, 1:8000)
Test each dilution on your tissue of interest
Evaluate signal-to-noise ratio at each concentration
Select the dilution that gives the best specific signal with minimal background
Tissue-Specific Considerations:
Higher antibody concentrations (1:500) may be needed for tissues with low PMEI28 expression
Lower concentrations (1:2000-1:8000) often work well for high-expression tissues
Consider reducing both antibody concentration and staining volume for tissues with high background
Research shows that antibody concentrations above 2.5 μg/mL often show high background with limited response to titration, while concentrations between 0.62-2.5 μg/mL typically reach saturation plateau. Many antibodies can be further diluted without compromising detection of positive cells .
Ensuring specificity when studying plant tissues that express multiple PMEI proteins can be challenging. Here are methodological approaches to ensure specificity :
Pre-absorption Controls:
Incubate the antibody with purified PMEI28 protein prior to the experiment
If the signal disappears, it confirms specificity for PMEI28
Knockout/Knockdown Verification:
Test the antibody in PMEI28 knockout or RNAi knockdown plant tissues
Absence or significant reduction of signal confirms specificity
Peptide Competition Assay:
Perform parallel experiments with antibody pre-incubated with the immunizing peptide
Signal reduction indicates specific binding
Cross-Reactivity Testing:
Express recombinant versions of related PMEIs (e.g., PMEI10, PMEI11, PMEI12)
Test antibody binding to determine potential cross-reactivity
Computational Epitope Analysis:
Perform in silico analysis of the antibody's epitope region across different PMEIs
Identify unique sequence regions specific to PMEI28
| Method | Advantages | Limitations | Required Materials |
|---|---|---|---|
| Pre-absorption | Direct evidence of specificity | Requires purified protein | Recombinant PMEI28 |
| Knockout Verification | Gold standard for specificity | Requires genetic resources | PMEI28 knockout plants |
| Peptide Competition | Simple to implement | Works only for peptide antibodies | Immunizing peptide |
| Cross-Reactivity Testing | Comprehensive specificity profile | Labor intensive | Multiple PMEI proteins |
| Computational Analysis | No wet lab work required | Predictive only | Sequence data, modeling software |
Fixation and antigen retrieval are critical steps for successful immunolocalization of PMEI28. Based on protocols for similar plant proteins :
Recommended Fixation Methods:
4% paraformaldehyde in phosphate-buffered saline (PBS) for 12-24 hours at 4°C
Alternative: Farmer's fixative (3:1 ethanol:acetic acid) for 24 hours at room temperature
For electron microscopy: 2.5% glutaraldehyde followed by 1% osmium tetroxide
Optimal Antigen Retrieval Protocols:
Heat-mediated: Citrate buffer (pH 6.0) for 20 minutes at 95°C
Enzymatic: Proteinase K (20 μg/mL) treatment for 10 minutes at room temperature
Combined approach: Low pH treatment followed by mild enzymatic digestion
Tissue-Specific Considerations:
Leaf tissues: Additional permeabilization with 0.1% Triton X-100 may be required
Root tissues: Extended fixation (24-48 hours) often improves results
Fruit tissues: Vacuum infiltration during fixation improves penetration
After fixation and sectioning, a blocking step with 3-5% BSA or normal serum from the secondary antibody host species is recommended to reduce background staining.
Quantitative assessment of PMEI28-PME interactions requires specialized antibody-based techniques. Based on methodologies used for other PMEI-PME interactions :
Co-Immunoprecipitation (Co-IP) with Quantification:
Immunoprecipitate PMEI28 using the specific antibody
Analyze co-precipitated PMEs by mass spectrometry or Western blotting
Quantify interaction strength using calibrated standards
Surface Plasmon Resonance (SPR):
Immobilize purified PMEI28 antibody on a sensor chip
Capture PMEI28 from plant extracts
Measure binding kinetics (kon, koff) of different PMEs
Calculate equilibrium dissociation constants (KD)
Förster Resonance Energy Transfer (FRET):
Label PMEI28 antibody with donor fluorophore
Label PME antibodies with acceptor fluorophore
Measure FRET efficiency to determine interaction proximity
Calculate interaction distances
Enzyme-Linked Immunosorbent Assay (ELISA)-Based Binding Assays:
Coat plates with PMEI28 antibody
Capture PMEI28 from plant extracts
Add purified PMEs and detect binding through PME-specific antibodies
Generate binding curves for different PMEs
| Method | Quantitative Parameter | Detection Limit | Advantages | Limitations |
|---|---|---|---|---|
| Co-IP + MS | Relative abundance | ~1 ng protein | Identifies novel interactors | Semi-quantitative |
| SPR | KD, kon, koff | 1-10 pM | Real-time kinetics | Requires specialized equipment |
| FRET | FRET efficiency, distance | 1-10 nm | Spatial information | Complex optimization |
| ELISA | EC50, Bmax | 0.1-1 ng/mL | High-throughput | Indirect measurement |
PMEI28 expression patterns during pathogen infection can be studied alongside other defense-related PMEIs to understand their coordinated roles. Based on studies of PMEIs in pathogen response :
Temporal Expression Profiling:
Use PMEI28 antibody for Western blot analysis at different time points post-infection
Compare with expression patterns of other defense-related PMEIs (e.g., PMEI10, PMEI11, PMEI12)
Correlate with pathogen progression and disease symptoms
Spatial Expression Analysis:
Perform immunohistochemistry using PMEI28 antibody on infected tissues
Map expression relative to infection sites
Compare localization with other PMEIs to identify spatial coordination
Research on Arabidopsis PMEIs shows distinct temporal expression patterns during pathogen infection:
PMEI3 shows early down-regulation (24 hpi) that continues through infection
PMEI11 is rapidly repressed (24 hpi), then induced (48 hpi), and declines (72 hpi)
PMEI10 and PMEI12 show significant induction at 48 hpi that increases at 72 hpi
Additionally, different PMEIs show varied responses to defense hormones:
Jasmonic acid (JA) induces maximum PMEI11 expression after 24 hours
Ethylene (ET) causes slow increase in PMEI expression, peaking at 30 hours
| PMEI | Early Response (0-24h) | Mid Response (24-48h) | Late Response (48-72h) | Primary Hormonal Regulation |
|---|---|---|---|---|
| PMEI3 | Down-regulation | Continued decrease | Lowest expression | Ethylene |
| PMEI10 | Minimal change | Significant induction | Further increase | Jasmonic acid |
| PMEI11 | Rapid repression | Induction | Decline | Jasmonic acid, OGs |
| PMEI12 | Minimal change | Significant induction | Further increase | Jasmonic acid |
| PMEI28* | Research needed using the antibody to establish precise patterns |
Note: The exact pattern for PMEI28 would need to be determined through research using the PMEI28 antibody.
Computational modeling can significantly enhance PMEI28 antibody research through epitope prediction and binding analysis :
Structural Modeling and Epitope Prediction:
Generate 3D models of PMEI28 using homology modeling based on known PMEI structures
Predict surface-exposed regions likely to serve as antibody epitopes
Calculate surface electrostatic potential to identify charged epitope regions
Analyze sequence conservation across species to identify unique epitope regions
Antibody-Antigen Docking Simulations:
Model the variable regions of the PMEI28 antibody
Perform computational docking to predict binding configurations
Calculate binding energies to identify high-affinity interactions
Simulate molecular dynamics to assess stability of antibody-antigen complexes
Machine Learning Approaches:
Train models on known antibody-antigen interactions
Predict PMEI28-specific binding based on sequence and structural features
Generate customized specificity profiles for antibody optimization
Design experiments to validate computational predictions
Current approaches allow researchers to:
Disentangle different binding modes associated with specific ligands
Design antibodies with customized specificity profiles
Predict cross-reactivity with related proteins
| Computational Method | Function | Required Input | Output | Applications |
|---|---|---|---|---|
| Homology Modeling | 3D structure prediction | PMEI28 sequence | Predicted 3D structure | Epitope mapping |
| Surface Analysis | Identification of exposed regions | 3D model | Surface maps | Antibody design |
| Molecular Docking | Binding prediction | Antibody and antigen structures | Binding configurations | Binding optimization |
| Machine Learning | Specificity prediction | Training data from related antibodies | Specificity profiles | Custom antibody design |
High background is a common challenge when working with antibodies in plant tissues. For PMEI28 antibody, the following methodological approaches can help reduce background based on research with similar antibodies :
Antibody Concentration Optimization:
High antibody concentrations (>2.5 μg/mL) often lead to increased background
Titrate antibody to find optimal concentration (typically 0.62-2.5 μg/mL)
Research shows fourfold dilutions from starting concentration allow systematic evaluation of signal-to-noise ratio
Blocking Improvements:
Extended blocking (2-4 hours) with 5% non-fat dry milk in TBS-T
Addition of 0.1-0.5% detergent (Triton X-100 or Tween-20) to reduce non-specific binding
Use of plant-specific blocking agents (e.g., 2% BSA with 10% normal serum)
Washing Protocol Optimization:
Increased washing duration (4-6 washes of 10 minutes each)
Higher detergent concentration in wash buffers (0.1-0.3% Tween-20)
Addition of salt (up to 500 mM NaCl) to wash buffers to reduce ionic interactions
Sample Preparation Improvements:
Pre-incubation of samples with pre-immune serum
Sample pre-clearing with Protein A/G beads
For plant tissues: pre-treatment with plant-specific Fc-blocking reagents
A study on antibody optimization found that antibody background in empty droplets constituted a major fraction of total sequencing reads and was skewed toward antibodies used at high concentrations targeting epitopes present in low amounts .
Distinguishing between active and inactive forms of PMEI28 requires specialized approaches that go beyond simple detection. Based on techniques developed for other PMEIs :
Activity-Based Detection:
Use biotinylated PME proteins as probes
Only active PMEI28 will form complexes with these probes
Detect complexes using the PMEI28 antibody and streptavidin-based detection
Conformation-Specific Antibody Approach:
Develop and use antibodies that specifically recognize the active conformation of PMEI28
Compare results with the total PMEI28 detected by standard antibodies
Calculate the ratio of active to total PMEI28
Complex Formation Analysis:
Use high-performance size-exclusion chromatography (HPSEC)
Detect PMEI28-PME complexes using the antibody
Only active PMEI28 will form these complexes
Research on PMEIs has shown that bPMEI (biotinylated PMEI) only detected active PME molecules, while anti-PME antibodies recognized both native and denatured PMEs. This complementary approach can be adapted for PMEI28 to distinguish between active and inactive forms .
Cross-reactivity issues can significantly impact PMEI28 antibody applications. Based on antibody cross-reactivity research and specificity engineering approaches :
Absorption Pre-Treatment:
Pre-incubate antibody with purified cross-reactive proteins
Remove antibodies bound to non-target proteins
Use the remaining antibody fraction for specific detection
Epitope-Focused Antibody Development:
Identify unique epitopes in PMEI28 not present in related proteins
Develop new antibodies targeting these unique regions
Validate specificity against a panel of related PMEIs
Two-Antibody Validation Approach:
Use two different antibodies targeting distinct epitopes on PMEI28
Only signals that colocalize from both antibodies are considered positive
This significantly reduces false positives from cross-reactivity
Computational Design and Engineering:
Research on antibody specificity has shown that computational models can successfully disentangle binding modes associated with chemically similar ligands and predict antibody sequences with customized specificity profiles .
| Strategy | Implementation | Advantages | Limitations |
|---|---|---|---|
| Absorption | Pre-incubate with cross-reactive proteins | Simple laboratory procedure | Reduces antibody yield |
| Epitope-Focused | Generate antibodies against unique regions | High specificity | Requires new antibody development |
| Two-Antibody | Use two antibodies targeting different epitopes | Excellent validation | Higher cost, complex protocols |
| Computational | In silico design of high-specificity antibodies | Rational design approach | Requires computational expertise |
PMEI28 antibody offers powerful tools for investigating cell wall modifications during plant defense responses :
Spatiotemporal Analysis of Defense Responses:
Track PMEI28 localization during pathogen infection using immunohistochemistry
Correlate PMEI28 expression with cell wall reinforcement at infection sites
Analyze relationship between PMEI28 expression and pectin methylesterification status
Defense Signaling Pathway Investigation:
Use PMEI28 antibody to study protein expression in response to defense hormones
Compare expression patterns following treatment with:
Jasmonic acid (JA)
Ethylene (ET)
Salicylic acid (SA)
Damage-associated molecular patterns (DAMPs)
Cell Wall Integrity Monitoring During Stress:
Combine PMEI28 immunodetection with cell wall modification assays
Analyze correlation between PMEI28 levels and:
Degree of pectin methylesterification
Cell wall porosity
Resistance to enzymatic degradation
Defense gene activation
Research has shown that PMEIs like AtPMEI10, AtPMEI11, and AtPMEI12 act as mediators of cell wall integrity maintenance in plant immunity, with their expression strictly regulated by jasmonic acid and ethylene signaling . PMEI28 research using the antibody could reveal whether it plays similar roles in rice.
Multi-parameter analyses using PMEI28 antibody can provide comprehensive insights into plant stress responses :
Multiplexed Immunofluorescence:
Combine PMEI28 antibody with antibodies against other stress-related proteins
Use spectrally distinct fluorophores for simultaneous detection
Analyze colocalization and expression correlation
Flow Cytometry and Cell Sorting:
Prepare protoplasts from stressed plant tissues
Label with PMEI28 antibody and cell-type specific markers
Sort cells based on PMEI28 expression levels
Perform downstream transcriptomic or proteomic analysis
Single-Cell Resolution Analysis:
Combine PMEI28 immunodetection with cellular imaging techniques
Correlate PMEI28 expression with:
Cell viability markers
Reactive oxygen species detection
Calcium signaling indicators
Pathogen presence markers
CITE-seq Adaptation for Plant Research:
Adapt Cellular Indexing of Transcriptomes and Epitopes by Sequencing (CITE-seq)
Use oligo-conjugated PMEI28 antibodies
Simultaneously profile protein expression and transcriptome at single-cell level
Research has shown that oligo-conjugated antibodies require careful titration for optimal signal-to-noise ratio, with most antibodies reaching saturation plateau at concentrations between 0.62 and 2.5 μg/mL .
| Approach | Parameters Measured | Resolution | Applications | Technical Considerations |
|---|---|---|---|---|
| Multiplexed IF | 3-5 proteins simultaneously | Cellular | Spatial protein relationships | Spectral overlap, antibody compatibility |
| Flow Cytometry | 5-10 parameters | Population level | Cell type-specific responses | Protoplast preparation, antibody validation |
| Single-Cell Imaging | PMEI28 + 3-4 cellular markers | Subcellular | Precise localization studies | High-resolution microscopy, signal amplification |
| CITE-seq | Protein + transcriptome | Single-cell | Integrated omics | Antibody oligonucleotide conjugation optimization |
PMEI28 antibody research can significantly contribute to engineering strategies for enhanced plant pathogen resistance :
Functional Characterization for Transgenic Approaches:
Use antibody to compare PMEI28 expression in resistant vs. susceptible varieties
Identify optimal expression levels and patterns for disease resistance
Design transgenic strategies based on expression data from antibody studies
Structure-Function Analysis for Protein Engineering:
Use antibody to purify and characterize native PMEI28
Determine critical regions for PME inhibition activity
Engineer improved PMEI28 variants with enhanced inhibitory properties
Screening and Phenotyping Tools for Breeding Programs:
Develop PMEI28 antibody-based assays to screen germplasm collections
Identify varieties with favorable PMEI28 expression patterns
Use as selection markers in breeding programs
Research has shown that plants overexpressing PMEIs (like AtPMEI1 or AtPMEI2) showed a lower level of PME activity, a higher degree of methylesterification of pectin, and reduced susceptibility to pathogens like Botrytis cinerea and Pectobacterium carotovorum . Similar strategies could be developed for PMEI28 based on antibody research findings.